169 related articles for article (PubMed ID: 2198414)
1. Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy.
Pattyn SR; Husser JA; Baquillon G; Maiga M; Jamet P
Lepr Rev; 1990 Jun; 61(2):151-6. PubMed ID: 2198414
[TBL] [Abstract][Full Text] [Related]
2. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of 3 therapeutic regimens in paucibacillary leprosy. Preliminary note].
Husser JA; Baquillon G; Pattyn SR
Acta Leprol; 1986; 4(4):447-52. PubMed ID: 3296615
[TBL] [Abstract][Full Text] [Related]
4. Antagonism between dapsone and rifampicin in experimental Mycobacterium leprae infections in mice.
Millan JP; Moulia-Pelat JP
Res Microbiol; 1989 Feb; 140(2):143-50. PubMed ID: 2678328
[TBL] [Abstract][Full Text] [Related]
5. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
Katoch K; Ramanathan U; Natrajan M; Bagga AK; Bhatia AS; Saxena RK; Ramu G
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):458-64. PubMed ID: 2746075
[TBL] [Abstract][Full Text] [Related]
6. A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin with a single dose of rifampicin followed by one year of daily dapsone. The Collaborative Study Group for the Treatment of Leprosy in Zaire.
Pattyn SR; Groenen G; Janssens L; Kuykens L; Mputu LB
Lepr Rev; 1991 Jun; 62(2):179-85. PubMed ID: 1870380
[TBL] [Abstract][Full Text] [Related]
7. A controlled therapeutic trial in paucibacillary leprosy comparing a single dose of rifampicin followed by 1 year of daily dapsone with 10 weekly doses of rifampicin.
Pattyn SR; Groenen G; Bourland J; Grillone S; Janssens L
Lepr Rev; 1987 Dec; 58(4):349-58. PubMed ID: 3323751
[No Abstract] [Full Text] [Related]
8. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
Gelber RH; Humphres RC; Fieldsteel AH
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
[TBL] [Abstract][Full Text] [Related]
9. Study of multidrug therapy in paucibacillary leprosy.
Kar PK; Sohi AS
J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
[TBL] [Abstract][Full Text] [Related]
10. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
Katoch K; Ramu G; Ramanathan U
Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
[TBL] [Abstract][Full Text] [Related]
12. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
Soares DJ; Neupane K; Britton WJ
Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
[TBL] [Abstract][Full Text] [Related]
13. [2 cases of paucibacillary leprosy resistant to dapsone].
Janssens L
Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
[TBL] [Abstract][Full Text] [Related]
14. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
Kumar B; Kaur S; Kaur I
Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
16. Relapse rate in paucibacillary leprosy patients after multidrug therapy in North Arcot District.
Ekambaram V; Rao MK
Indian J Lepr; 1991; 63(1):34-42. PubMed ID: 1919088
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial of two single-dose treatments for paucibacillary leprosy.
Pattyn SR; Ghys P; Janssens L; Tshilumba K; Kuykens L; Karibushi N; Denis P
Lepr Rev; 1994 Mar; 65(1):45-57. PubMed ID: 8201835
[TBL] [Abstract][Full Text] [Related]
19. Multidrug therapy for treatment of paucibacillary leprosy in western Kenya--preliminary communications.
Orege PA; Obura M; Okelo C; Okuku P; Makokha S; Nyawalo J
East Afr Med J; 1990 Sep; 67(9):632-9. PubMed ID: 2253572
[TBL] [Abstract][Full Text] [Related]
20. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
Chandorkar AG; Burte NP; Gade RK; Bulakh PM
Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]